Structural analysis of TIFA: Insight into TIFA-dependent signal transduction in innate immunity.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
20 03 2020
Historique:
received: 11 11 2019
accepted: 03 03 2020
entrez: 22 3 2020
pubmed: 22 3 2020
medline: 7 1 2021
Statut: epublish

Résumé

TRAF-interacting protein with a forkhead-associated (FHA) domain (TIFA), originally identified as an adaptor protein of TRAF6, has recently been shown to be involved in innate immunity, induced by a pathogen-associated molecular pattern (PAMP). ADP-β-D-manno-heptose, a newly identified PAMP, binds to alpha-kinase 1 (ALPK1) and activates its kinase activity to phosphorylate TIFA. Phosphorylation triggers TIFA oligomerisation and formation of a subsequent TIFA-TRAF6 oligomeric complex for ubiquitination of TRAF6, eventually leading to NF-κB activation. However, the structural basis of TIFA-dependent TRAF6 signalling, especially oligomer formation of the TIFA-TRAF6 complex remains unknown. In the present study, we determined the crystal structures of mouse TIFA and two TIFA mutants-Thr9 mutated to either Asp or Glu to mimic the phosphorylation state-to obtain the structural information for oligomer formation of the TIFA-TRAF6 complex. Crystal structures show the dimer formation of mouse TIFA to be similar to that of human TIFA, which was previously reported. This dimeric structure is consistent with the solution structure obtained from small angle X-ray scattering analysis. In addition to the structural analysis, we examined the molecular assembly of TIFA and the TIFA-TRAF6 complex by size-exclusion chromatography, and suggested a model for the TIFA-TRAF6 signalling complex.

Identifiants

pubmed: 32198460
doi: 10.1038/s41598-020-61972-6
pii: 10.1038/s41598-020-61972-6
pmc: PMC7083832
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
Intracellular Signaling Peptides and Proteins 0
NF-kappa B 0
Pathogen-Associated Molecular Pattern Molecules 0
TNF Receptor-Associated Factor 6 0
Tifab protein, human 0
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins 0
Protein Kinases EC 2.7.-
ALPK1 protein, human EC 2.7.11.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5152

Références

Takatsuna, H. et al. Identification of TIFA as an adapter protein that links tumor necrosis factor receptor-associated factor 6 (TRAF6) to interleukin-1 (IL-1) receptor-associated kinase-1 (IRAK-1) in IL-1 receptor signaling. J. Biol. Chem. 278, 12144–12150 (2003).
doi: 10.1074/jbc.M300720200
Kanamori, M., Suzuki, H., Saito, R., Muramatsu, M. & Hayashizaki, Y. T2BP, a Novel TRAF2 Binding Protein, Can Activate NF-κB and AP-1 without TNF Stimulation. Biochem. Biophys. Res. Commun. 290, 1108–1113 (2002).
doi: 10.1006/bbrc.2001.6315
Ishida, T. et al. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271, 28745–28748 (1996).
doi: 10.1074/jbc.271.46.28745
Mahajan, A. et al. Structure and Function of the Phosphothreonine-Specific FHA Domain. Sci. Signal. 1, re12 (2008).
doi: 10.1126/scisignal.151re12
Ea, C.-K., Sun, L., Inoue, J.-I. & Chen, Z. J. TIFA activates IkappaB kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6. Proc. Natl. Acad. Sci. USA 101, 15318–15323 (2004).
doi: 10.1073/pnas.0404132101
Matsumura, T. et al. TIFAB inhibits TIFA, TRAF-interacting protein with a forkhead-associated domain. Biochem. Biophys. Res. Commun. 317, 230–234 (2004).
doi: 10.1016/j.bbrc.2004.03.030
Matsumura, T., Kawamura-Tsuzuku, J., Yamamoto, T., Semba, K. & Inoue, J.-I. TRAF-interacting protein with a forkhead-associated domain B (TIFAB) is a negative regulator of the TRAF6-induced cellular functions. J. Biochem. 146, 375–381 (2009).
doi: 10.1093/jb/mvp080
Huang, C.-C. F. et al. Intermolecular binding between TIFA-FHA and TIFA-pT mediates tumor necrosis factor alpha stimulation and NF-κB activation. Mol. Cell. Biol. 32, 2664–2673 (2012).
doi: 10.1128/MCB.00438-12
Gaudet, R. G. et al. INNATE IMMUNITY. Cytosolic detection of the bacterial metabolite HBP activates TIFA-dependent innate immunity. Science 348, 1251–1255 (2015).
doi: 10.1126/science.aaa4921
Milivojevic, M. et al. ALPK1 controls TIFA/TRAF6-dependent innate immunity against heptose-1,7-bisphosphate of gram-negative bacteria. PLoS Pathog. 13, e1006224 (2017).
doi: 10.1371/journal.ppat.1006224
Zimmermann, S. et al. ALPK1- and TIFA-Dependent Innate Immune Response Triggered by the Helicobacter pylori Type IV Secretion System. Cell Rep. 20, 2384–2395 (2017).
doi: 10.1016/j.celrep.2017.08.039
Zhou, P. et al. Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose. Nature 561, 122–126 (2018).
doi: 10.1038/s41586-018-0433-3
García‐Weber, D. et al. ADP‐heptose is a newly identified pathogen‐associated molecular pattern of Shigella flexneri. EMBO Rep. e46943, https://doi.org/10.15252/embr.201846943 (2018).
Pfannkuch, L. et al. ADP heptose, a novel pathogen-associated molecular pattern identified in Helicobacter pylori. FASEB J. 33, 9087–9099,  https://doi.org/10.1096/fj.201802555R (2019).
Weng, J.-H. et al. Uncovering the Mechanism of Forkhead-Associated Domain-Mediated TIFA Oligomerization That Plays a Central Role in Immune Responses. Biochemistry 54, 6219–6229 (2015).
doi: 10.1021/acs.biochem.5b00500
Yin, Q. et al. E2 interaction and dimerization in the crystal structure of TRAF6. Nat. Struct. Mol. Biol. 16, 658–666 (2009).
doi: 10.1038/nsmb.1605
Middleton, A. J. et al. The activity of TRAF RING homo- and heterodimers is regulated by zinc finger 1. Nat. Commun. 8, 1788 (2017).
doi: 10.1038/s41467-017-01665-3
Fu, T.-M., Shen, C., Li, Q., Zhang, P. & Wu, H. Mechanism of ubiquitin transfer promoted by TRAF6. Proc. Natl. Acad. Sci. 115, 1783–1788 (2018).
doi: 10.1073/pnas.1721788115
Ye, H. et al. Distinct molecular mechanism for initiating TRAF6 signalling. Nature 418, 443–447 (2002).
doi: 10.1038/nature00888
Huang, W. C. et al. Binding and Enhanced Binding between Key Immunity Proteins TRAF6 and TIFA. ChemBioChem 20, 140–146 (2019).
pubmed: 30378729 pmcid: 30378729
Pearlman, S. M., Serber, Z. & Ferrell, J. E. A mechanism for the evolution of phosphorylation sites. Cell 147, 934–946 (2011).
doi: 10.1016/j.cell.2011.08.052
Bernadó, P., Mylonas, E., Petoukhov, M. V., Blackledge, M. & Svergun, D. I. Structural characterization of flexible proteins using small-angle X-ray scattering. J. Am. Chem. Soc. 129, 5656–5664 (2007).
doi: 10.1021/ja069124n
Tria, G., Mertens, H. D. T., Kachala, M. & Svergun, D. I. Advanced ensemble modelling of flexible macromolecules using X-ray solution scattering. IUCrJ 2, 207–217 (2015).
doi: 10.1107/S205225251500202X
Park, Y. C., Burkitt, V., Villa, A. R., Tong, L. & Wu, H. Structural basis for self-association and receptor recognition of human TRAF2. Nature 398, 533–538 (1999).
doi: 10.1038/19110
Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997).
doi: 10.1016/S0076-6879(97)76066-X
Kabsch, W. XDS. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 125–132 (2010).
doi: 10.1107/S0907444909047337
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 213–221 (2010).
doi: 10.1107/S0907444909052925
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D Biol. Crystallogr. 60, 2126–2132 (2004).
doi: 10.1107/S0907444904019158
Vagin, A. & Teplyakov, A. Molecular replacement with MOLREP. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 22–25 (2010).
doi: 10.1107/S0907444909042589
Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. Sect. D Biol. Crystallogr. 67, 235–242 (2011).
doi: 10.1107/S0907444910045749
Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of Macromolecular Structures by the Maximum-Likelihood Method. Acta Crystallogr. Sect. D Biol. Crystallogr. 53, 240–255 (1997).
doi: 10.1107/S0907444996012255
The PyMOL Molecular Graphics System, Version 2.0 Schrödinger, LLC.
Petoukhov, M. V. et al. New developments in the ATSAS program package for small-angle scattering data analysis. J. Appl. Crystallogr. 45, 342–350 (2012).
doi: 10.1107/S0021889812007662
Shimizu, N. et al. Software Development for Analysis of Small-angle X-ray Scattering Data. AIP Conf. Proc. 1741, 050017 (2016).
doi: 10.1063/1.4952937
Konarev, P. V., Volkov, V. V., Sokolova, A. V., Koch, M. H. J. & Svergun, D. I. PRIMUS: a Windows PC-based system for small-angle scattering data analysis. J. Appl. Cryst. 36, 1277–1282 (2003).
doi: 10.1107/S0021889803012779
Svergun, D. I. Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J. Appl. Cryst. 25, 495–503 (1992).
doi: 10.1107/S0021889892001663
Svergun, D. I. Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophys. J. 76, 2879–2886 (1999).
doi: 10.1016/S0006-3495(99)77443-6
Volkov, V. V. & Svergun, D. I. Uniqueness of ab initio shape determination in small-angle scattering. J. Appl. Cryst. 36, 860–864 (2003).
doi: 10.1107/S0021889803000268
Kozin, M. B. & Svergun, D. I. Automated matching of high- and low-resolution structural models. J. Appl. Cryst. 34, 33–41 (2001).
doi: 10.1107/S0021889800014126
Larkin, M. A. et al. Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947–2948 (2007).
doi: 10.1093/bioinformatics/btm404

Auteurs

Teruya Nakamura (T)

Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan. tnaka@gpo.kumamoto-u.ac.jp.
Priority Organization for Innovation and Excellence, Kumamoto University, Kumamoto, Japan. tnaka@gpo.kumamoto-u.ac.jp.

Chie Hashikawa (C)

Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.

Kohtaro Okabe (K)

School of Pharmacy, Kumamoto University, Kumamoto, Japan.

Yuya Yokote (Y)

School of Pharmacy, Kumamoto University, Kumamoto, Japan.

Mami Chirifu (M)

Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.

Sachiko Toma-Fukai (S)

Graduate School of Science and Technology, Nara Institute of Science and Technology, Ikoma, Japan.

Narushi Nakamura (N)

School of Pharmacy, Kumamoto University, Kumamoto, Japan.

Mihoko Matsuo (M)

Priority Organization for Innovation and Excellence, Kumamoto University, Kumamoto, Japan.

Miho Kamikariya (M)

School of Pharmacy, Kumamoto University, Kumamoto, Japan.

Yoshinari Okamoto (Y)

Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.

Jin Gohda (J)

Research Center for Asian Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Taishin Akiyama (T)

Laboratory for Immune Homeostasis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Kentaro Semba (K)

Department of Life Science and Medical Bioscience, Waseda University, Tokyo, Japan.

Shinji Ikemizu (S)

Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.

Masami Otsuka (M)

Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.

Jun-Ichiro Inoue (JI)

Research Center for Asian Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Division of Cellular and Molecular Biology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Yuriko Yamagata (Y)

Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH